These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 15147569)
1. Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination? Gillmore JD; Hutchinson WL; Herbert J; Bybee A; Mitchell DA; Hasserjian RP; Yamamura K; Suzuki M; Sabin CA; Pepys MB Immunology; 2004 Jun; 112(2):255-64. PubMed ID: 15147569 [TBL] [Abstract][Full Text] [Related]
2. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Bickerstaff MC; Botto M; Hutchinson WL; Herbert J; Tennent GA; Bybee A; Mitchell DA; Cook HT; Butler PJ; Walport MJ; Pepys MB Nat Med; 1999 Jun; 5(6):694-7. PubMed ID: 10371509 [TBL] [Abstract][Full Text] [Related]
3. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Noursadeghi M; Bickerstaff MC; Gallimore JR; Herbert J; Cohen J; Pepys MB Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14584-9. PubMed ID: 11121061 [TBL] [Abstract][Full Text] [Related]
4. Mice lacking serum amyloid P component do not necessarily develop severe autoimmune disease. Soma M; Tamaoki T; Kawano H; Ito S; Sakamoto M; Okada Y; Ozaki Y; Kanba S; Hamada Y; Ishihara T; Maeda S Biochem Biophys Res Commun; 2001 Aug; 286(1):200-5. PubMed ID: 11485329 [TBL] [Abstract][Full Text] [Related]
5. Liver-specific and high-level expression of human serum amyloid P component gene in transgenic mice. Iwanaga T; Wakasugi S; Inomoto T; Uehira M; Ohnishi S; Nishiguchi S; Araki K; Uno M; Miyazaki J; Maeda S Dev Genet; 1989; 10(5):365-71. PubMed ID: 2598499 [TBL] [Abstract][Full Text] [Related]
6. Chromatin breakdown during necrosis by serum Dnase1 and the plasminogen system. Napirei M; Wulf S; Mannherz HG Arthritis Rheum; 2004 Jun; 50(6):1873-83. PubMed ID: 15188364 [TBL] [Abstract][Full Text] [Related]
7. Oncostatin M deficiency leads to thymic hypoplasia, accumulation of apoptotic thymocytes and glomerulonephritis. Esashi E; Ito H; Minehata K; Saito S; Morikawa Y; Miyajima A Eur J Immunol; 2009 Jun; 39(6):1664-70. PubMed ID: 19384873 [TBL] [Abstract][Full Text] [Related]
8. Autoimmunity and immune complex disease after neonatal induction of transplantation tolerance in mice. Goldman M; Feng HM; Engers H; Hochman A; Louis J; Lambert PH J Immunol; 1983 Jul; 131(1):251-8. PubMed ID: 6223073 [TBL] [Abstract][Full Text] [Related]
9. Dying cells program their expedient disposal: serum amyloid P component upregulation in vivo and in vitro induced by photodynamic therapy of cancer. Merchant S; Sun J; Korbelik M Photochem Photobiol Sci; 2007 Dec; 6(12):1284-9. PubMed ID: 18046483 [TBL] [Abstract][Full Text] [Related]
10. Influenza virus infection is not affected by serum amyloid P component. Herbert J; Hutchinson WL; Carr J; Ives J; Jakob-Roetne R; Yamamura K; Suzuki M; Pepys MB Mol Med; 2002 Jan; 8(1):9-15. PubMed ID: 11984001 [TBL] [Abstract][Full Text] [Related]
11. Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition. Maeda S Amyloid; 2003 Aug; 10 Suppl 1():17-20. PubMed ID: 14640037 [TBL] [Abstract][Full Text] [Related]
12. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity. Jellusova J; Wellmann U; Amann K; Winkler TH; Nitschke L J Immunol; 2010 Apr; 184(7):3618-27. PubMed ID: 20200274 [TBL] [Abstract][Full Text] [Related]
14. Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages. Bijl M; Horst G; Bijzet J; Bootsma H; Limburg PC; Kallenberg CG Arthritis Rheum; 2003 Jan; 48(1):248-54. PubMed ID: 12528126 [TBL] [Abstract][Full Text] [Related]
15. Serum amyloid P component and autoimmune parameters in the assessment of arthritis activity in MRL/lpr/lpr mice. Rordorf-Adam C; Serban D; Pataki A; Grüninger M Clin Exp Immunol; 1985 Sep; 61(3):509-16. PubMed ID: 3878240 [TBL] [Abstract][Full Text] [Related]
16. The combined effect of BCL-2 over-expression and E2F2 deficiency induces an autoimmune syndrome in non-susceptible mouse strain C57BL/6. Marín-Vidalled MJ; Bolívar A; Zubiaga A; López-Hoyos M Autoimmunity; 2010 Mar; 43(2):111-20. PubMed ID: 20187704 [TBL] [Abstract][Full Text] [Related]
17. Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits. Baltz ML; Caspi D; Evans DJ; Rowe IF; Hind CR; Pepys MB Clin Exp Immunol; 1986 Dec; 66(3):691-700. PubMed ID: 3568456 [TBL] [Abstract][Full Text] [Related]
18. The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells. Fukuyama H; Nimmerjahn F; Ravetch JV Nat Immunol; 2005 Jan; 6(1):99-106. PubMed ID: 15592473 [TBL] [Abstract][Full Text] [Related]
19. Formation of experimental murine AA amyloid fibrils in SAP-deficient mice: high resolution ultrastructural study. Inoue S; Kawano H; Ishihara T; Maeda S; Ohno S Amyloid; 2005 Sep; 12(3):157-63. PubMed ID: 16194870 [TBL] [Abstract][Full Text] [Related]
20. The mouse immune response to human fibrinogen reveals an autoimmune component against mouse fibrinogen. Rubin B; Matron C Cell Immunol; 2005 Jan; 233(1):41-52. PubMed ID: 15876427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]